drugset / Trial / NCT00961662
A Clinical Study to Evaluate the Effect of Naturlose (Tagatose)
RandomizedParallel-groupSingle-blindTreatment
Summary
This study is a six-month, prospective, randomized, multicenter, single- blind, controlled clinical study to evaluate the effect of three low-doses of Naturlose (Tagatose) on glycemic control and safety in subjects with Type 2 diabetes under diet control and exercise. The subjects were randomized in one of the 3 arms receiving 2.5, 5 or 7.5 gm of Tagatose.
Timeline
- Start
- 2008-02
- Primary completion
- 2010-08
- Completion
- 2010-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tagatose | Small molecule | 2.5 g | Oral |
| Subject | Tagatose | Small molecule | 5 g | Oral |
| Subject | Tagatose | Small molecule | 7.5 g | Oral |